ORASURE TECHNOLOGIES, INC Cash and Cash Equivalents
ORASURE TECHNOLOGIES, INC (OSUR) had Cash and Cash Equivalents of $160.58 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-07
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $160.58M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $176.96M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $199.28M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $216.48M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $160.58M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $176.96M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $199.28M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $216.48M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $234.58M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $247.57M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $267.76M 10-K · filed 2026-03-09 | |
| 2024-09-30 | $278.57M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $258.24M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $247.15M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $290.41M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $217.53M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $185.94M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $90.19M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $83.98M 10-K · filed 2024-03-11 | |
| 2022-09-30 | $75.20M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $66.16M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $70.72M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $116.76M 10-K · filed 2023-03-03 | |
| 2021-09-30 | $134.96M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $158.12M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $177.68M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $160.80M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $162.86M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $173.87M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $83.36M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $75.72M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $85.47M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $72.57M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $69.52M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $88.44M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $78.15M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $71.05M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $64.04M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $71.03M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $76.77M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $104.87M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $120.85M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $107.96M 10-K · filed 2018-02-28 | |
| 2016-09-30 | $111.73M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $105.70M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $94.56M 10-Q · filed 2017-05-09 | |
| 2015-12-31 | $94.09M 10-Q · filed 2017-05-09 | |
| 2015-09-30 | $100.68M 10-Q · filed 2016-11-08 | |
| 2015-06-30 | $83.40M 10-Q · filed 2016-08-08 | |
| 2015-03-31 | $85.55M 10-Q · filed 2016-05-10 | |
| 2014-12-31 | $92.87M 10-K · filed 2017-03-14 | |
| 2014-09-30 | $93.86M 10-Q · filed 2015-11-06 | |
| 2014-06-30 | $75.83M 10-Q · filed 2015-08-07 | |
| 2014-03-31 | $84.19M 10-Q · filed 2015-05-08 | |
| 2013-12-31 | $93.19M 10-K · filed 2017-03-14 | |
| 2013-09-30 | $82.59M 10-Q · filed 2014-11-07 | |
| 2013-06-30 | $76.96M 10-Q · filed 2014-08-06 | |
| 2013-03-31 | $79.28M 10-Q · filed 2014-05-08 | |
| 2013-01-01 | $87.89M 10-K · filed 2016-03-14 | |
| 2012-12-31 | $87.89M 10-K · filed 2015-03-12 | |
| 2012-09-30 | $89.42M 10-Q · filed 2013-11-07 | $89.42M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $23.27M 10-Q · filed 2013-08-08 | $23.27M 10-Q · filed 2012-08-08 |
| 2012-03-31 | $22.81M 10-Q · filed 2013-05-09 | $22.81M 10-Q · filed 2012-05-09 |
| 2011-12-31 | $23.88M 10-K · filed 2015-03-12 | $23.88M 10-K · filed 2012-03-14 |
| 2011-09-30 | $21.37M 10-Q · filed 2012-11-09 | |
| 2011-06-30 | $75.40M 10-Q · filed 2012-08-08 | |
| 2011-03-31 | $70.54M 10-Q · filed 2012-05-09 | |
| 2010-12-31 | $73.84M 10-K · filed 2014-03-14 | $73.84M 10-Q · filed 2011-08-05 |
| 2010-09-30 | $71.70M 10-Q · filed 2011-11-09 | |
| 2010-06-30 | $72.55M 10-Q · filed 2011-08-05 | |
| 2009-12-31 | $74.93M 10-K · filed 2013-03-13 | $74.93M 10-Q · filed 2011-08-05 |
| 2008-12-31 | $39.57M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |